Brief: First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
June 5 (Reuters) - Imunon Inc IMNN.O :
* FIRST PARTICIPANTS VACCINATED IN IMUNON’S IMNN-101 PHASE 1
CLINICAL TRIAL
Source text for Eikon: ID:nGNXbFDtky
Further company coverage: IMNN.O
((Reuters.Briefs@thomsonreuters.com;))